logo
How Rad-140 Enhances Workout Intensity and Recovery

How Rad-140 Enhances Workout Intensity and Recovery

In the world of high-performance fitness and bodybuilding, recovery and training intensity are often what separate plateaus from progress. One compound that's consistently catching the attention of athletes looking for that extra edge is Rad-140, also known as Testolone. As a selective androgen receptor modulator (SARM), it offers muscle-enhancing benefits that are both powerful and specific. For those seeking lean muscle gains without the harsh side effects of traditional anabolic steroids, the increasing number of options like Rad 140 for sale has made it a go-to among lifters who value results and precision.
But what really makes Rad-140 stand out is how it supports not just muscle development, but also your body's ability to recover from intense training. When combined with smart programming and nutrition, this compound can completely change how you train and how you bounce back.
Rad-140 was originally developed to combat muscle wasting in patients with degenerative conditions. However, its potential in sports performance has become undeniable. The compound binds selectively to androgen receptors in muscle and bone tissue, activating anabolic signals without triggering the broader side effects typically associated with steroids.
What does this mean in real-life results?
Users often report a significant boost in strength within the first 1–2 weeks of using Rad-140. This translates to more reps, heavier lifts, and greater workload capacity. Whether you're focused on hypertrophy, powerlifting, or athletic conditioning, that extra push helps break through training barriers.
One of Rad-140's most appreciated benefits is how it shortens the time needed between hard training sessions. Microtears in muscle fibers heal more efficiently, allowing you to train more frequently without overreaching.
This becomes especially crucial during strength cycles or cutting phases where muscle preservation is vital.
Rad-140 supports recovery through several physiological mechanisms. The first is its role in muscle protein synthesis, which becomes more efficient when androgen receptors are activated.
Another aspect is hormonal balance. While Rad-140 can suppress natural testosterone production to a degree, it doesn't convert to estrogen. This means users don't typically experience the water retention, bloating, or emotional fluctuations that come with estrogenic side effects making recovery cleaner and more linear.
Interestingly, compounds like the Itpp SARM are often discussed alongside Rad-140 for their role in oxygen utilization and muscular endurance. While Rad-140 is more anabolic, stacking strategies that include complementary compounds may amplify recovery even further. However, these should be handled with care and strategic planning.
Most beginners start with 10 mg per day, while more experienced users may go up to 20 mg. It has a relatively long half-life, so once-daily dosing is sufficient. A typical cycle runs 8 to 12 weeks, followed by post-cycle therapy.
Rad-140 performs best when paired with a solid resistance training plan and adequate protein intake. If you're running a deficit (cutting), this compound helps preserve muscle. If you're in a surplus (bulking), expect lean, dry gains without unnecessary fat or water weight.
Although Rad-140 doesn't aromatize, it can suppress endogenous testosterone. A mild PCT lasting 4–6 weeks is usually sufficient to restore hormonal balance. Users often turn to natural testosterone boosters or selective estrogen receptor modulators (SERMs) to assist the recovery phase.
Rad-140 doesn't promise overnight miracles, but its performance-enhancing potential is real. Based on user feedback and community experiences, here's what's typically seen during a standard cycle: 3–7 pounds of lean mass added in 8–10 weeks
added in 8–10 weeks 10–20% increase in strength
Improved vascularity and definition , especially during cutting
, especially during cutting Faster recovery between training days, with less soreness
A look at do SARMs expire and compound stability is worth noting here. Like other SARMs, Rad-140 should be stored correctly typically in a cool, dark place to maintain potency. If you're sourcing from less-regulated suppliers, always check for third-party testing to ensure quality and shelf-life.
Despite its clean profile, Rad-140 isn't side-effect-free. The most common issues include: Test suppression – more noticeable at higher doses or longer cycles
– more noticeable at higher doses or longer cycles Sleep disruption – some users report lighter sleep toward the end of a cycle
– some users report lighter sleep toward the end of a cycle Mild aggression or irritability
Hair shedding – rare but possible with higher androgenic activity
These can usually be managed with responsible use, cycle breaks, and proper PCT.
Compared to other compounds like Ostarine or LGD-4033, Rad-140 tends to provide stronger anabolic effects without the added weight or puffiness. It's particularly useful for bodybuilders, power athletes, and even cross-trainers who want strength without sacrificing lean conditioning.
Its clean profile and effective recovery benefits make it ideal for: Deload weeks when athletes still want to maintain strength
when athletes still want to maintain strength Cutting cycles where muscle preservation is a priority
where muscle preservation is a priority Overreach training periods to reduce the risk of injury
Across lifting forums, social media groups, and private circles, Rad-140's reputation continues to rise:
'I added almost 6 pounds of clean mass in 8 weeks and didn't feel flat once.'
'My deadlift jumped by 40 lbs by the end of the cycle. Zero bloat. Felt great.'
'Stacked with Cardarine for cardio. Recovery was next level.'
These results reflect disciplined usage, proper dosing, and structured training—not just a reliance on the compound itself.
Rad-140 continues to earn its spot among the most researched and respected SARMs in the fitness world. With its impressive balance of muscle-building and recovery-enhancing properties, it helps bridge the gap between hard training and optimal results.
It's not a shortcut but a strategic addition to an already strong routine. If your training is consistent and your diet is dialed in, Rad-140 can help you push harder, recover smarter, and grow leaner without the baggage that comes with traditional anabolic agents.
TIME BUSINESS NEWS
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Rad-140 Enhances Workout Intensity and Recovery
How Rad-140 Enhances Workout Intensity and Recovery

Time Business News

time3 days ago

  • Time Business News

How Rad-140 Enhances Workout Intensity and Recovery

In the world of high-performance fitness and bodybuilding, recovery and training intensity are often what separate plateaus from progress. One compound that's consistently catching the attention of athletes looking for that extra edge is Rad-140, also known as Testolone. As a selective androgen receptor modulator (SARM), it offers muscle-enhancing benefits that are both powerful and specific. For those seeking lean muscle gains without the harsh side effects of traditional anabolic steroids, the increasing number of options like Rad 140 for sale has made it a go-to among lifters who value results and precision. But what really makes Rad-140 stand out is how it supports not just muscle development, but also your body's ability to recover from intense training. When combined with smart programming and nutrition, this compound can completely change how you train and how you bounce back. Rad-140 was originally developed to combat muscle wasting in patients with degenerative conditions. However, its potential in sports performance has become undeniable. The compound binds selectively to androgen receptors in muscle and bone tissue, activating anabolic signals without triggering the broader side effects typically associated with steroids. What does this mean in real-life results? Users often report a significant boost in strength within the first 1–2 weeks of using Rad-140. This translates to more reps, heavier lifts, and greater workload capacity. Whether you're focused on hypertrophy, powerlifting, or athletic conditioning, that extra push helps break through training barriers. One of Rad-140's most appreciated benefits is how it shortens the time needed between hard training sessions. Microtears in muscle fibers heal more efficiently, allowing you to train more frequently without overreaching. This becomes especially crucial during strength cycles or cutting phases where muscle preservation is vital. Rad-140 supports recovery through several physiological mechanisms. The first is its role in muscle protein synthesis, which becomes more efficient when androgen receptors are activated. Another aspect is hormonal balance. While Rad-140 can suppress natural testosterone production to a degree, it doesn't convert to estrogen. This means users don't typically experience the water retention, bloating, or emotional fluctuations that come with estrogenic side effects making recovery cleaner and more linear. Interestingly, compounds like the Itpp SARM are often discussed alongside Rad-140 for their role in oxygen utilization and muscular endurance. While Rad-140 is more anabolic, stacking strategies that include complementary compounds may amplify recovery even further. However, these should be handled with care and strategic planning. Most beginners start with 10 mg per day, while more experienced users may go up to 20 mg. It has a relatively long half-life, so once-daily dosing is sufficient. A typical cycle runs 8 to 12 weeks, followed by post-cycle therapy. Rad-140 performs best when paired with a solid resistance training plan and adequate protein intake. If you're running a deficit (cutting), this compound helps preserve muscle. If you're in a surplus (bulking), expect lean, dry gains without unnecessary fat or water weight. Although Rad-140 doesn't aromatize, it can suppress endogenous testosterone. A mild PCT lasting 4–6 weeks is usually sufficient to restore hormonal balance. Users often turn to natural testosterone boosters or selective estrogen receptor modulators (SERMs) to assist the recovery phase. Rad-140 doesn't promise overnight miracles, but its performance-enhancing potential is real. Based on user feedback and community experiences, here's what's typically seen during a standard cycle: 3–7 pounds of lean mass added in 8–10 weeks added in 8–10 weeks 10–20% increase in strength Improved vascularity and definition , especially during cutting , especially during cutting Faster recovery between training days, with less soreness A look at do SARMs expire and compound stability is worth noting here. Like other SARMs, Rad-140 should be stored correctly typically in a cool, dark place to maintain potency. If you're sourcing from less-regulated suppliers, always check for third-party testing to ensure quality and shelf-life. Despite its clean profile, Rad-140 isn't side-effect-free. The most common issues include: Test suppression – more noticeable at higher doses or longer cycles – more noticeable at higher doses or longer cycles Sleep disruption – some users report lighter sleep toward the end of a cycle – some users report lighter sleep toward the end of a cycle Mild aggression or irritability Hair shedding – rare but possible with higher androgenic activity These can usually be managed with responsible use, cycle breaks, and proper PCT. Compared to other compounds like Ostarine or LGD-4033, Rad-140 tends to provide stronger anabolic effects without the added weight or puffiness. It's particularly useful for bodybuilders, power athletes, and even cross-trainers who want strength without sacrificing lean conditioning. Its clean profile and effective recovery benefits make it ideal for: Deload weeks when athletes still want to maintain strength when athletes still want to maintain strength Cutting cycles where muscle preservation is a priority where muscle preservation is a priority Overreach training periods to reduce the risk of injury Across lifting forums, social media groups, and private circles, Rad-140's reputation continues to rise: 'I added almost 6 pounds of clean mass in 8 weeks and didn't feel flat once.' 'My deadlift jumped by 40 lbs by the end of the cycle. Zero bloat. Felt great.' 'Stacked with Cardarine for cardio. Recovery was next level.' These results reflect disciplined usage, proper dosing, and structured training—not just a reliance on the compound itself. Rad-140 continues to earn its spot among the most researched and respected SARMs in the fitness world. With its impressive balance of muscle-building and recovery-enhancing properties, it helps bridge the gap between hard training and optimal results. It's not a shortcut but a strategic addition to an already strong routine. If your training is consistent and your diet is dialed in, Rad-140 can help you push harder, recover smarter, and grow leaner without the baggage that comes with traditional anabolic agents. TIME BUSINESS NEWS

AITX's RAD to Deploy RIO for State Emergency Services Department
AITX's RAD to Deploy RIO for State Emergency Services Department

Yahoo

time01-07-2025

  • Yahoo

AITX's RAD to Deploy RIO for State Emergency Services Department

Initial Deployment Follows Two Years of Collaboration and Rigorous Field Testing with State Emergency Authorities Detroit, Michigan--(Newsfile Corp. - July 1, 2025) - Artificial Intelligence Technology Solutions, Inc. (OTC Pink: AITX) (the "Company"), a global leader in AI-driven security and productivity solutions for enterprise clients, today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD), will soon deploy a RIO™ 360 solar-powered security tower at a remote, high-security installation operated by a U.S. state agency. This initial deployment was contracted through the state's emergency management division following an extensive two-year engagement that included long-term field testing and rigorous evaluation of RAD's technology. Artist's depiction of a RAD RIO 360 solar tower positioned in a desolate, remote area. To view an enhanced version of this graphic, please visit: The high-priority site presents complex logistical and safety challenges, including geographic isolation, environmental hazards, and limited infrastructure. RAD's RIO was selected after successfully demonstrating consistent reliability and autonomous operation in demanding field tests. As more public agencies seek independent, portable solutions for locations where traditional security measures are ineffective or cost-prohibitive, RIO is proving to be a compelling answer to this growing need. A contributing factor in the agency's decision to move forward with RAD was the Company's successful completion of its SOC 2 Type 2 audit. This independent validation of RAD's internal controls and data protection protocols provided the necessary assurance for a client operating in a sensitive and high-security environment. For many government and enterprise clients, SOC 2 Type 2 compliance is a baseline requirement when evaluating technology partners for mission-critical deployments. "We are honored to support this important mission," said Steve Reinharz, CEO/CTO of AITX and RAD. "This deployment is the result of a long-term effort by our team to meet the rigorous standards of a client that prioritizes performance, reliability, and innovation. We see this as a significant milestone, with the potential to open new channels for growth and further demonstrate RAD's unique capabilities in complex, high-security environments." This initial deployment represents a strategic foothold with one of the most discerning clients RAD has engaged to date. The Company believes that successful execution at this location could lead to a substantial expansion of RAD's presence across multiple sites managed by the agency. Discussions regarding additional deployments are already underway, reflecting the client's recognition of RAD's ability to deliver reliable, autonomous security in mission-critical scenarios. RAD invites government agencies, infrastructure managers, and security professionals to explore how RIO and its supporting technologies are addressing the challenges of remote and high-security environments. To learn more about RAD's security solutions or to request a private demonstration, visit or contact the RAD sales team today. Sitting atop a standard RIO 360 configuration are two ROSA™ units. ROSA is a multiple award-winning, compact, self-contained, portable, security and communication solution that can be installed and activated in about 15 minutes. ROSA's AI-driven security analytics include human, firearm, vehicle detection, license plate recognition, responsive digital signage and audio messaging, and complete integration with RAD's software suite notification and autonomous response library. Two-way communication is optimized for cellular, including live video from ROSA's high-resolution, full-color, always-on cameras. RAD has published six Case Studies detailing how ROSA has helped eliminate instances of theft, trespassing and loitering at retail centers, hospital campuses, multi-family communities, car rental locations and construction sites across the country. AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the nearly $50 billion (US) security and guarding services industry1 through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers these tremendous cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house. The Company's operations and internal controls have been validated through successful completion of its SOC 2 Type 2 audit, reinforcing the Company's credibility with enterprise and government clients who require strict data protection and security compliance. RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time. About Artificial Intelligence Technology Solutions (AITX) AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-R, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit and or follow Steve Reinharz on X @SteveReinharz. CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price. ### Steve Reinharz949-636-7060@SteveReinharz 1 To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Icon Group and Varian Expand Global Partnership to Deliver Advanced Cancer Technology Across the UK
Icon Group and Varian Expand Global Partnership to Deliver Advanced Cancer Technology Across the UK

Business Wire

time26-06-2025

  • Business Wire

Icon Group and Varian Expand Global Partnership to Deliver Advanced Cancer Technology Across the UK

LONDON--(BUSINESS WIRE)--Icon Group, a global leader in integrated cancer care, has announced a significant new agreement with Varian, a Siemens Healthineers company, involving an investment of more than USD $18.7 million to expand access to cutting-edge, world-class cancer treatment technology across the United Kingdom. The agreement includes the rollout of Varian's advanced TrueBeam linear accelerators, along with next-generation imaging and software platforms such as RapidArc Dynamic (RAD), HyperSight, IDENTIFY, and a continued pipeline of new technology, designed to deliver faster, highly precise, patient-centred care. This investment reinforces Icon's ongoing commitment to increasing access to world-class, precision-led cancer care and marks the first installation of this full suite of comprehensive Varian hardware and software in the UK. The technology will be rolled out across Icon Cancer Centre London and three new locations in Brighton, Warwickshire, and Derby, with further installations planned to support Icon's growing footprint in the region. Icon Europe CEO, Aldo Rolfo said this technology will increase access to world-class care. 'At Icon, we're market leaders in introducing the absolute latest in radiotherapy technologies and treatments and ensuring we increase access to world-class care to communities we serve,' said Aldo. 'This large investment with Varian enables us to continue leading in precision cancer care and improving access to treatment and better outcomes for patients across the UK.' Enhancing patient experience and outcomes The new agreement will introduce Varian's most innovative technologies to UK patients, delivering faster treatment times, more precise imaging and delivery, and streamlined workflows that aim to improve the overall treatment experience: TrueBeam – an advanced linear accelerator (radiation therapy treatment machine) designed to deliver high-speed, image-guided radiation therapy for a wide range of cancers. RapidArc Dynamic (RAD) – a state-of-the-art planning and delivery platform that reduces treatment planning time by up to 70% while enhancing plan quality and reducing dose exposure to critical organs. HyperSight – advanced cone-beam CT imaging delivering clearer, faster images, that enhance anatomical visualisation and support more precise treatment delivery, while also helping streamline workflows by reducing image acquisition time. IDENTIFY – real-time surface-guided radiotherapy (SGRT) that increases treatment accuracy and can significantly reduce, and in many cases eliminate, the need for permanents tattoo markings, a sometime unfriendly reminder of a patient's diagnosis. The first installations will take place at Icon Cancer Centre London, with other sites following later in 2026. Icon Group's UK Chief Medical Officer, Dr Penny Kechagioglou said this new technology is a game-changer. 'This technology marks a new benchmark for radiotherapy in the UK,' said Dr Kechagioglou. 'There is currently an underutilisation of radiotherapy treatment, with fewer than 30% of cancer patients receiving it, less than the global recommended rate of 40 – 50% of cancer diagnosis 1. 'This is a real win for cancer patients who will benefit from timely access to highly advanced non-invasive radiotherapy designed to improve both patient experience and outcomes.' Head of Varian Europe, Middle East and Africa, Virve Sarja is looking forward to rolling out this technology. 'We're proud to strengthen our collaboration with Icon in the UK,' said Virve. 'This partnership reflects a shared commitment to expanding access to cutting edge radiotherapy technologies in the region and redefining what's possible in cancer treatment. By combining innovation with a strong focus on patient care, we're helping to raise the standard of treatment and move closer to a world without fear of cancer.' © 2025 VARIAN MEDICAL SYSTEMS, INC. All trademarks are the property of their respective owners. References 1 Cancer Research UK About Icon Group Icon Group is a leading integrated cancer care provider with a global reach across Australia, New Zealand, ASEAN, Mainland China and the United Kingdom. Icon is built on a strong but simple mission - to deliver the best care possible to as many people as possible, as close to home as possible. The group brings together all aspects of quality cancer care including medical oncology, haematology, radiation oncology, research, theranostics, pharmacy and compounding to deliver a truly integrated, end-to-end seamless service for cancer patients. With more than 3,500 team members, a network of more than 350 doctors, over 55 cancer centres, six compounding facilities and operational support of 70 plus pharmacies, Icon is delivering world-leading care and helping address the global cancer burden. For more information visit and follow Icon Group on LinkedIn at About Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit Icon and Varian's global partnership Icon Group and Varian have a long history of collaboration in delivering advanced cancer care across Australia, New Zealand, Asia, and now the UK. Icon clinicians and medical professionals are active members of Varian's global AI and RapidArc Dynamic consortiums and are engaged in clinical research and product development initiatives worldwide. The expanded partnership in the UK also builds on a five-year professional services and research agreement between Icon and Varian established in 2022 and highlights a shared commitment to innovation, access, and improved patient outcomes. QR700024577

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store